SEC Form 3 · accession 0001209191-16-119843
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Levande
Director · Other
Period of report
May 13, 2016
Accepted (ET)
May 13, 2016 · 3:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 168,750 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.67 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 75,655 | — | D |
| Warrants (right to buy)F2 | $2.67 | holding | — | — | — | Nov 6, 2014 | Nov 6, 2021 | Common Stock | 45,638 | — | D |
Explanation of responses
- F1The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on May 1, 2015 and will end on February 1, 2018, subject to the Reporting Person's continued service through each vesting date.
- F2Subject to adjustment as set forth in the warrant.